文献速递眼底病与葡萄膜炎

增生性糖尿病视网膜病变治疗患者失访的预测因素

Predictors of Lost to Follow-Up in Patients Being Treated for Proliferative Diabetic Retinopathy.
PubMed 文献 · Am J Ophthalmol · 2020-03-31

该回顾性队列研究纳入418例接受抗VEGF玻璃体腔注射和/或全视网膜光凝的增生性糖尿病视网膜病变成人患者,发现61%(256例)失访。多因素分析显示非英语母语、年龄56岁以上、居住距离≤20英里、合并症>5种、就诊科室≥20个、非眼科预约缺席>10%及仅接受全视网膜光凝均与失访正相关。

要点

  • 61%的增生性糖尿病视网膜病变治疗患者失访。
  • 非英语母语、年龄56岁以上、居住距离≤20英里增加失访风险。
  • 合并症>5种、就诊科室≥20个、非眼科预约缺席>10%及仅接受全视网膜光凝亦与失访相关。

核心结论

  • 该机构4年间接受治疗的增生性糖尿病视网膜病变患者失访比例高。
  • 识别失访高风险患者可能有助于选择治疗方式和进行患者咨询。

研究设计与样本

  • 回顾性队列研究,纳入2014年1月1日至2018年6月1日期间接受抗VEGF玻璃体腔注射和/或全视网膜光凝的418例增生性糖尿病视网膜病变成人患者。

主要发现

  • 418例患者中256例(61%)失访。

临床怎么用

  • 对具有非英语母语、年龄56岁以上、居住距离≤20英里、合并症>5种、就诊科室≥20个、非眼科预约缺席>10%或仅接受全视网膜光凝等特征的患者,应加强失访风险识别与咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To identify risk factors for patients with proliferative diabetic retinopathy (PDR) who are lost to follow-up (LTFU) while undergoing intravitreal injections of anti-VEGF (IVIs) and/or panretinal photocoagulation (PRP) at an urban institution. DESIGN: Retrospective cohort study. METHODS: A chart review was performed in a total of 418 adult patients with PDR who received IVI and/or PRP between January 1, 2014, and June 1, 2018, at the authors' institution. Rates of LTFU, risk factors associated with LTFU, and vision outcomes were assessed. RESULTS: Of a total of 418 patients, 256 patients (61%) were LTFU. Risk factors positively associated with LTFU on multivariate analysis included non-English as the primary language (odds ratio [OR], 1.83; P = .006); age 56-65 years old (OR, 1.86; P = .014); age older than 65 years (OR, 1.94; P = .027) compared to age 55 years or younger; living 20 miles or less from the institution (OR, 2.68; P = .009); having greater than 5 comorbidities (OR, 2.38; P = .034); seeing 20 or more distinct departments (OR, 4.66; P = .007); missing more than 10% of non-eye care appointments (OR, 1.61; P = .038); and receiving only PRP compared to only IVIs (OR, 1.93; P = .031). CONCLUSIONS: A high percentage of patients treated for PDR at the authors' institution were LTFU over a 4-year time span. Identifying patients at high risk for being LTFU may help in choosing treatment modality and appropriate patient counseling.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Green M, Tien T, Ness S, et al. Predictors of Lost to Follow-Up in Patients Being Treated for Proliferative Diabetic Retinopathy. Am J Ophthalmol. 2020. PMID: 32243878. doi:10.1016/j.ajo.2020.03.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。